Additionally, Pacific Biosciences will benefit from a 17-month ... including the Vega sequencing system and SPRQ chemistry for the Revio system, aimed at expanding their market reach.

Additionally, Pacific Biosciences will benefit from a 17-month base rent abatement ... including the Vega sequencing system and SPRQ chemistry for the Revio system, aimed at expanding their market ...

Pacific Biosciences of California ... Benchtop platform and enhancing the value and usability of Revio with Spark Chemistry. Leveraging recent innovations to substantially increase sequencing ...

Pacific Biosciences' Q4'24 results were another ... hurt in part by customers working down inventories ahead of a new chemistry launch. Gross margin rose about 12 points from the prior year ...

AbbVie, Thermo Fisher Scientific, Recursion Pharmaceuticals, Bloom Energy, and Iovance Biotherapeutics are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool.

The development process usually combines principles of materials science, engineering, biology, chemistry, and computer science ... contributing to regional market growth. Asia Pacific is projected to ...

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.